Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Filip Janku files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Markus Warmuth - $951K of GLUE open-market activity in the last 12 months
- Edmund Dunn - $483K of GLUE open-market activity in the last 12 months
- Sharon Townson - $424K of GLUE open-market activity in the last 12 months
- Anthony M. Manning - $411K of GLUE open-market activity in the last 12 months
- Jennifer Champoux - $311K of GLUE open-market activity in the last 12 months
- Philip Nickson - $151K of GLUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Filip Janku?
Filip Janku is a corporate insider, tracked as Chief Medical Officer of Monte Rosa Therapeutics, Inc. (GLUE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Filip Janku submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Filip Janku been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.38M) across all tracked filings.
Where can I see all of Filip Janku's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Filip Janku and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
